Startup · $76m raised
Sydney, NSW
Every investor coverage indicates participated in a round Omniscient Neurotechnology raised.
| Investor | Rounds | Invested |
|---|---|---|
| Gina Rinehart | Series B | - |
| Gretel Packer | Series B | - |
| Kerr Neilson | Series B | - |
| NRF Corporation | Series D+ | $20,000,000 |
| OIF Ventures | Series D+ | - |
| Will Vicars | Series B | - |
Companies Omniscient Neurotechnology acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Omniscient Neurotechnology. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of three Australian raises: Omniscient Neurotechnology's in-progress Series D drawing a $20m national fund investment, deceased-estates platform EstateXchange's first raise, and fitness software firm Hapana's Microequities-led round.
Sydney neurotech firm Omniscient has banked a Series C from Gina Rinehart and Will Vicars, funding a push into the United States for its connectomics platform.
Sydney medtech Omniscient Neurotechnology, which applies machine learning to mapping brain networks, has reportedly raised a $40 million Series B valuing it at $400 million, with backers including Gina Rinehart, Gretel Packer, Kerr Neilson and Will Vicars.